BST02

· BioSyngen Pte Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BST02, covering 2024-07-30 to 2024-07-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer [Phase 1]